About Correlia Biosystems
Correlia Biosystems is a private company based in Berkeley, California. It has reported $10,829,038 raised in two offerings on Form D since October 2020. Its chief executive is Akwasi Apori.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 1, 2023 | May 9, 2023 | $1,254,212of $3.2M target | 2 | $627K | Equity, Rights offeringRule 506(b) | Form D ↗ |
| Oct 2, 2020 | Oct 16, 2020 | $9,574,826fully sold | 41 | $233K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $10,829,038 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Correlia Biosystems's Form D filed May 9, 2023.
KK
Kittu Kolluri
Director
First appears on the Form D that Correlia Biosystems filed on May 9, 2023; on 1 of its 2 filings.
KA
Kursad Araz
Director
First appears on the Form D that Correlia Biosystems filed on May 9, 2023; on 1 of its 2 filings.
AA
Akwasi Apori
Chief Executive Officer and director
On every Form D that Correlia Biosystems has filed: 2 filings, from Oct 16, 2020 to May 9, 2023.
Earlier filings also listed
- Samuel Tia · directorLast listed on the Form D that Correlia Biosystems filed on October 16, 2020; on 1 of its 2 filings.